Immuneering Corporation Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Immuneering Corporation stock issued during period, value, new issues for the quarter ending 2025-09-30 was $1.34M, a 68.30% decline year-over-year.
- Immuneering Corporation stock issued during period, value, new issues for the quarter ending 2025-03-31 was $13.68M.
- Immuneering Corporation stock issued during period, value, new issues for the quarter ending 2024-09-30 was $4.24M.
- Immuneering Corporation stock issued during period, value, new issues for the quarter ending 2023-06-30 was $28.00M.
- Immuneering Corporation stock issued during period, value, new issues for fiscal 2025 was $15.02M, a 254.46% increase from fiscal 2024.
- Immuneering Corporation stock issued during period, value, new issues for fiscal 2024 was $4.24M, a 84.86% decline from fiscal 2023.
- Immuneering Corporation stock issued during period, value, new issues for fiscal 2023 was $28.00M.
- Immuneering Corporation stock issued during period, value, new issues for fiscal 2021 was $118.19M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $15.02M 10-K · filed 2026-03-06 | |
| 2025-09-30 | $1.34M 10-Q · filed 2025-11-12 | |
| 2025-03-31 | $13.68M 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $4.24M 10-K · filed 2025-03-20 | |
| 2024-09-30 | $4.24M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $28.00M 10-K · filed 2025-03-20 | |
| 2023-06-30 | $28.00M 10-Q · filed 2024-11-13 | |
| 2021-12-31 | $118.19M 10-K · filed 2023-03-06 | |
| 2021-09-30 | $118.19M 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |